June 29th DEA Hearing: The Marijuana Industry That Stole the Word "Medical" Is Now Choking on It"State licensed cannabis programs stole the language of medicine without ever submitting to FDA drug development standards that make a botanical product medicine" says Duane Boise CEO MMJ International Holdings.
Former DEA Section Chief Steps Forward to Challenge Marijuana Rescheduling Process"As DEA Prepares for June 29 Hearing, MMJ International Holdings Brings Forward the Very Experts Who Built, Enforced, and Understand the Federal Drug Approval System" stated Duane Boise CEO MMJ International Holdings.
Cannabis Industry Attorney Concedes D.C. Circuit Challenge Could Reverse Marijuana Rescheduling"For weeks investors have been told that the legal challenges to marijuana rescheduling were merely procedural speed bumps. Now a respected cannabis industry attorney has acknowledged what MMJ has maintained all along: if the D.C. Circuit reaches the merits, the Schedule III order faces substantial legal risk. Courts decide cases based on law and evidence-not industry wishful thinking," said Duane Boise, CEO of MMJ International Holdings.
MMJ BioPharma Cultivation Receives Marijuana Grow Equipment Creating Marijuana Center of ExcellencePROVIDENCE, RI / ACCESSWIRE / July 7, 2022 / https://vimeo.com/715029558 MMJ BioPharma Cultivation, a DEA API Bulk Manufacturer applicant to grow marijuana today received their advanced precision cultivation equipment. With this innovative cultivation technology MMJ BioPharma Cultivation will be able to reproduce quality strain specific cannabis to meet the DEA's marijuana definition of chemical reproducibility and quality.
DEA Delays MMJ Clinical Trials MS and HD, yet FDA Issues Dozens of CBD Warning LettersDEA Fails It's Congressional Mandate To Facilitate FDA Marijuana Clinical Trials & Pharmaceutical Development For Suffering Patients PROVIDENCE, RI / ACCESSWIRE / May 10, 2022 / Attorneys representing the MMJ biopharma conglomerate, a federal cannabis cultivation license applicant, filed a petition in federal court today, citing that the Drug Enforcement Agency (DEA) is taking too long to issue a determination for its application. The
DEA Marijuana Application Process in Violation of Congressional MandateCongress contains no possibilities for extension or exceptions to the MMJ CULTIVATION application determination deadline in accordance with section 304(c)..." 21 U.S. Code 823(i)(2)(a) PROVIDENCE, RI / ACCESSWIRE / May 5, 2022 / MMJ conglomerate is asking the federal court for an emergency intervention with the U.S. Drug Enforcement Administration (DEA) in its quest to grow pharmaceutical-grade marijuana for use in clinical trials into
DEA Delays Marijuana Researcher - MMJ Request Federal Court Action For Emergency Motion To ExpediteOur newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
DEA Approved Marijuana Research Center of Excellence Awards SMS Security ContractMMJ BioPharma Cultivation is anticipating the imminent DEA approval for its federal API Bulk Manufacturing Registration PROVIDENCE, RI / ACCESSWIRE / April 5, 2022 / MMJ BioPharma Labs and MMJ BioPharma Cultivation has awarded a contract to Anthony Manfredi and Louis Stravato of Safety Management Solutions for the security and safety enforcement of their cannabis research facilities. Safety Management Solutions (SMS) was selected from the field
DEA Delays MMJ Manufacturing of Marijuana Drug for Multiple Sclerosis and Huntington's Disease PatientsDEA application process is being delayed for years for reasons unknown thus negatively impacting the progression of the drug development for patients suffering from Multiple Sclerosis and Huntington's disease. PROVIDENCE, RI / ACCESSWIRE / March 13, 2022 / MMJ International Holdings, in collaboration with a specialty pharmaceutical solutions company, has been manufacturing gelatin capsule medicines based on compounds found in cannabis, The
